Evidence map›Paper›PMID 33916540›Full record

ArticleMolecules (Basel, Switzerland)2021

Modulation of Renal Function in a Metabolic Syndrome Rat Model by Antioxidants in

Félix Leao Rodríguez-Fierros, Verónica Guarner-Lans, María Elena Soto, Linaloe Manzano-Pech, Eulises Díaz-Díaz, Elizabeth Soria-Castro, María Esther Rubio-Ruiz, Francisco Jiménez-Trejo, Israel Pérez-Torres

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Effect ofInternational journal of molecular sciences · 2023
    Article
  5. Natural Products in Renal-Associated Drug Discovery.Antioxidants (Basel, Switzerland) · 2023
    Review
  6. Article
  7. Oxidative medicine and cellular longevity · 2023
    Article
  8. Foods (Basel, Switzerland) · 2022
    Review
  9. Physiological Effects and Human Health Benefits ofPharmaceuticals (Basel, Switzerland) · 2022
    Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Félix Leao Rodríguez-FierrosDepartment of Cardiovascular Biomedicine, Instituto Nacional de Cardiología "Ignacio Chávez", Juan Badiano 1, Sección XVI, Tlalpan, Mexico City 14080, Mexico.
Verónica Guarner-LansDepartment of Physiology, Instituto Nacional de Cardiología "Ignacio Chávez", Juan Badiano 1, Sección XVI, Tlalpan, Mexico City 14080, Mexico.ORCID 0000-0002-2655-7590
María Elena SotoDepartment of Immunology, Instituto Nacional de Cardiología "Ignacio Chávez", Juan Badiano 1, Sección XVI, Tlalpan, Mexico City 14080, Mexico.ORCID 0000-0003-1332-2888
Linaloe Manzano-PechDepartment of Cardiovascular Biomedicine, Instituto Nacional de Cardiología "Ignacio Chávez", Juan Badiano 1, Sección XVI, Tlalpan, Mexico City 14080, Mexico.
Eulises Díaz-DíazDepartment of Reproductive Biology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Sección XVI, Tlalpan, Mexico City 14000, Mexico.
Elizabeth Soria-CastroDepartment of Cardiovascular Biomedicine, Instituto Nacional de Cardiología "Ignacio Chávez", Juan Badiano 1, Sección XVI, Tlalpan, Mexico City 14080, Mexico.
María Esther Rubio-RuizDepartment of Physiology, Instituto Nacional de Cardiología "Ignacio Chávez", Juan Badiano 1, Sección XVI, Tlalpan, Mexico City 14080, Mexico.ORCID 0000-0002-8844-2078
Francisco Jiménez-TrejoDepartment of Reproductive Biology, Instituto Nacional de Pediatría, Insurgentes Sur No. 3700-C, Coyoacán, Mexico City 04530, Mexico.
Israel Pérez-TorresDepartment of Cardiovascular Biomedicine, Instituto Nacional de Cardiología "Ignacio Chávez", Juan Badiano 1, Sección XVI, Tlalpan, Mexico City 14080, Mexico.ORCID 0000-0001-6510-2954
Instituto Nacional de Cardiología · MXInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXInstituto Nacional de Pediatria · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic syndrome (MS) is the association of three or more pathologies among which obesity, hypertension, insulin resistance, dyslipidemia, and diabetes are included. It causes oxidative stress (OS) and renal dysfunction.

Indexed as

AlbuminuriaAnimalsAnti-Obesity AgentsAntioxidantsAscorbic AcidBlood PressureBody WeightCreatinineGlomerular Filtration RateGlutathioneGlutathione PeroxidaseGlutathione TransferaseHibiscusHypolipidemic AgentsInsulinKidneyAnti-Obesity AgentsAntioxidantsAscorbic AcidCreatinineGlutathioneGlutathione PeroxidaseGlutathione TransferaseHypolipidemic AgentsInsulinLeptinPlant ExtractsSuperoxide DismutaseTriglyceridesHibiscus sabdariffa L.kidneymetabolic syndromeoxidative stressrenal function

Identifiers

PMID33916540
PMCPMC8038460
OpenAlexW3150594961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.